Results 1 to 10 of about 13,003 (157)

Chinese Clinical Named Entity Recognition with ALBERT and MHA Mechanism

open access: yesEvidence-Based Complementary and Alternative Medicine, Volume 2022, Issue 1, 2022., 2022
Traditional clinical named entity recognition methods fail to balance the effectiveness of feature extraction of unstructured text and the complexity of neural network models. We propose a model based on ALBERT and a multihead attention (MHA) mechanism to solve this problem.
Dongmei Li   +4 more
wiley   +1 more source

Chinese Medical Entity Recognition Model Based on Character and Word Vector Fusion

open access: yesScientific Programming, Volume 2021, Issue 1, 2021., 2021
The medical information carried in electronic medical records has high clinical research value, and medical named entity recognition is the key to extracting valuable information from large‐scale medical texts. At present, most of the studies on Chinese medical named entity recognition are based on character vector model or word vector model.
Qinghui Zhang   +5 more
wiley   +1 more source

Corrigendum to “Yiqi Huayu Jiedu Decoction Inhibits the Invasion and Metastasis of Gastric Cancer Cells through TGF‐β/Smad Pathway”

open access: yes, 2021
Evidence-Based Complementary and Alternative Medicine, Volume 2021, Issue 1, 2021.
Ting-Ting Wu   +10 more
wiley   +1 more source

The Level of Nesfatin‐1 in a Mouse Gastric Cancer Model and Its Role in Gastric Cancer Comorbid with Depression

open access: yesGeneral Psychiatry, Volume 30, Issue 2, Page 119-126, July 2018., 2018
Background The incidence of depressive symptoms is higher in cancer patients. And depression can also affect the occurrence, development and outcome of cancer through the neuroendocrine‐immune‐network system. Objective To study the level of Nesfatin‐1 in the plasma and brain tissue and its role in the pathogenesis in gastric cancer comorbid with ...
Nan Zhang   +6 more
wiley   +1 more source

胃癌根治性手术前后TM4SF1水平及病理特征变化研究

open access: yesZhongguo shiyan zhenduanxue, 2021
目的探讨胃癌根治性手术前后TM4SF1(跨膜4超家族成员1)水平及病理特征变化。方法选取天津市宁河区医院2016年6月到2019年6月共收治的80例胃癌患者进行回顾性分析,所有患者均行胃癌根治术,分析胃癌患者根治术前胃癌组织及邻近非胃癌组织中TM4SF1表达,胃癌患者根治术后胃粘膜中TM4SF1水平表达与胃癌根治术前TM4SF1表达水平对比,并对比所有患者胃癌根治术前和手术1年后的临床病理特征。结果在同一切段中,TM4SF1在GC组织中呈阴性表达,在相邻非癌组织中呈阳性表达。在我们的患者队列中 ...
郭俊龙, 梁滨, 田伟军
doaj  

胃癌患者血清sB7-H3检测的临床意义

open access: yesZhongguo shiyan zhenduanxue, 2022
目的 探讨检测胃癌患者血清中sB7-H3水平的临床意义。方法 应用酶联免疫吸附测定(ELISA)法检测60例胃癌患者、40例慢性胃炎患者和30例健康志愿者血清sB7-H3水平,免疫组织化学法(Immunohistochemistry,IHC)检测胃癌及对应癌旁组织中B7-H3蛋白表达,并分析胃癌患者血清sB7-H3水平在临床病理因素及胃癌组织B7-H3蛋白表达各组间差异是否具有统计学意义。结果 胃癌组血清sB7-H3浓度为(25.5±11.4)ng/ml,显著高于慢性胃炎组(9.1±7.8)ng ...
陈忠, 朱燕, 毛飞
doaj  

N-Myc-Interacting Protein (NMI)蛋白抑制胃癌上皮间质转化(EMT)的研究 [PDF]

open access: yes, 2016
上皮间质转化(EMT)与多种生长因子和转录因子相关,可以通过多种信号转导通路起作用,并在胚胎发育、损伤修复、许多慢性疾病及肿瘤的发生和发展中起着重要的作用,然而EMT在胃癌发生过程中的分子机制并不清楚。 核因子-κB(NF-κB)可以与多种基因启动子部位的κB位点发生特异性的结合并促进其转录表达,进而调控肿瘤的发生,影响EMT的进程。我们的工作发现了一个新的通过调控抑制NF-κB通路调控胃癌中EMT的蛋白-NMI(N-MycandSTATinteractor)。研究结果显示 ...
侯静静
core  

The Role and Mechanism of RARα in the Development of Gastric Carcinoma [PDF]

open access: yes, 2016
尽管胃癌的发病率在下降,但其死亡率仍位于全球第二位。由于缺乏有效的早期诊断方法,大多数胃癌病人在确诊时已到了晚期阶段。因此亟需寻找新的胃癌诊断与治疗的分子靶点。许多研究表明视黄酸受体在肿瘤的进程中起着重要的作用,然而,RARα与肿瘤的关系尚不清楚。本论文以胃癌为研究对象,阐明RARα在胃癌发生发展中的作用及其分子机制。 本论文主要通过Q-PCR、Westernblot、IHC/ICC等方法研究胃癌组织和细胞中RARα的表达情况及其临床意义。利用MTT、细胞集落形成、裸鼠皮下异种成瘤、流式细胞术 ...
任红岳
core  

15. ゼミノームの放射線治療成績(第5回佐藤外科例会,第488回千葉医学会例会) [PDF]

open access: yes, 2016
Performance of the MDSINE inference algorithms on simulated data with different sequencing depths. Simulations assumed an underlying dynamical systems model with ten species observed over 30 days with 27 time points sampled and an invading species at ...
Belinda Tzen (3567806)   +14 more
core   +5 more sources

Home - About - Disclaimer - Privacy